Vertex Pharmaceuticals VRTX
$547.09 +$4.59 (+0.85%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $548.00 +0.17%
Open$531.53
Prev close$542.50
Day range$531.53 – $548.76
Volume1.27M
Market cap$138.71B
P/E (TTM)35.2
Dividend yield–
Analyst view
ConsensusBuy
Analysts21
Average target$626.06+14.4% vs. price
- Buy 95%
- Hold 5%
Low $563.00Now $547.09Avg $626.06High $725.00
Recent rating changes
The last 20 actions on file set price targets from $563.00 to $725.00, averaging $626.10.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 4 Nov 2026 | UBS | BUY | $640.00 |
| 4 Nov 2026 | Maxim Group | BUY | $620.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $641.00 |
| 4 Nov 2026 | Barclays | BUY | $626.00 |
| 3 Nov 2026 | TD Cowen | BUY | $575.00 |
| 3 Nov 2026 | UBS | BUY | $640.00 |
| 3 Nov 2026 | Maxim Group | BUY | $620.00 |
| 3 Nov 2026 | Scotiabank | BUY | $660.00 |
| 3 Nov 2026 | Morgan Stanley | BUY | $660.00 |
| 3 Nov 2026 | Stifel | HOLD | $563.00 |
| 3 Nov 2026 | BMO Capital | BUY | $620.00 |
| 3 Nov 2026 | Citi | BUY | $585.00 |
| 3 Nov 2026 | Goldman Sachs | BUY | $725.00 |
| 3 Nov 2026 | H.C. Wainwright | BUY | $641.00 |
| 3 Nov 2026 | J.P. Morgan | BUY | $570.00 |
| 2 Nov 2026 | Cantor Fitzgerald | BUY | $619.00 |
| 2 Nov 2026 | Wells Fargo | BUY | $650.00 |
| 2 Nov 2026 | UBS | BUY | $615.00 |
| 2 Nov 2026 | BofA Securities | BUY | $667.00 |
| 2 Nov 2026 | Citi | BUY | $585.00 |
No comments yet — be the first to weigh in on VRTX.
Sign in to join the discussion.